Inventiva
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 2 weeks.
- Its last 3 Sell calls were actually followed by a +22% average gain three months out - this one has bounced back faster than the signal expected.
- Recent price momentum is -25.8% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 4.4% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 02:27 UTC
Data coverage: 4 of 6 factors. Missing data is not a zero score.
The radar needs all six factors. Available grades are shown below.
Valuation N/A
How expensive the stock is versus earnings, sales and its own 5-year history.
Not enough data to grade this factor.
Growth N/A
How fast revenue, profit and free cash flow are compounding.
Not enough data to grade this factor.
Profitability F
How much profit the business keeps from each dollar of sales and capital.
| Operating margin | -2,964.2% | Better than 2% |
| Net margin | -7,899.6% | Better than 1% |
| Return on equity | -1,642.6% | Better than 0% |
| Return on invested capital | -251.1% | Better than 0% |
Momentum D
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -32.9% | Better than 16% |
| 6-month return | -38.1% | Better than 13% |
| 12-month return (ex latest month) | -13.7% | Better than 20% |
| Distance below 52-week high | 56.9% | Better than 13% |
Financial Health C+
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 3.2x | Better than 75% |
| Debt to assets | 24.0% | Better than 50% |
| Interest coverage | -9.6x | Better than 13% |
Analyst View A+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 100.0% | Better than 77% |
| Upside to average target | 396.8% | Better than 99% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 3.45
- Open
- 3.44
- Day range
- 3.13 - 3.44
- Avg price
- 3.24
- Volume
- 3.02M
- Turnover
- 9.80M
- Turnover ratei
- 1.65%
- Volume ratioi
- 1.05
- Amplitudei
- 8.99%
- 52-week rangei
- 2.82 - 7.29
Valuation
- P/Ei
- -1.51
- P/E (TTM)i
- -5.36
- P/Bi
- 11.59
- EPSi
- -2.08
- Book value / shi
- 0.27
- Net profit
- -498.29M
- Net assets
- 64.80M
Share structure
- Market cap
- 750.78M
- Float capi
- 574.00M
- Shares out
- 239.10M
- Float sharesi
- 182.80M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2020-07-10
56.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-4.16M net over the window
Short interest
- Shares short
- 10.35M
- % of floati
- 4.38%
- Days to coveri
- 3.50
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Inventiva (IVA)?
Inventiva last traded at 3.14. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Inventiva's market cap?
About 750.78M.
What is the P/E ratio of Inventiva?
The trailing twelve-month P/E is -5.36. The Valuation tab shows it against the stock's own five-year range.
Does Inventiva pay a dividend?
Inventiva does not currently pay a regular dividend.
Is Inventiva a buy according to analysts?
The consensus of 10 analysts is a Buy rating, with an average 12-month price target of 15.60, which implies 396.8% upside from the current price. This is not investment advice.
What is Inventiva's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Inventiva a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 20:02:27 · For reference only, not investment advice and not tailored to your situation.
Inventiva discussion 0 comments